Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001548668 | SCV001768621 | likely benign | not provided | 2020-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002405233 | SCV002673227 | benign | Cardiovascular phenotype | 2019-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002495878 | SCV002802280 | benign | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-09-01 | criteria provided, single submitter | clinical testing |